- Home
- VERI vs TLSI Comparison
VERI vs TLSI Comparison
Compare VERI & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERI
- TLSI
- Stock Information
- Founded
- VERI 2014
- TLSI 2010
- Country
- VERI United States
- TLSI United States
- Employees
- VERI N/A
- TLSI N/A
- Industry
- VERI EDP Services
- TLSI Medical Specialities
- Sector
- VERI Technology
- TLSI Health Care
- Exchange
- VERI Nasdaq
- TLSI Nasdaq
- Market Cap
- VERI 148.1M
- TLSI 158.0M
- IPO Year
- VERI 2017
- TLSI N/A
- Fundamental
- Price
- VERI $2.85
- TLSI $5.77
- Analyst Decision
- VERI Buy
- TLSI Strong Buy
- Analyst Count
- VERI 2
- TLSI 6
- Target Price
- VERI $3.38
- TLSI $11.75
- AVG Volume (30 Days)
- VERI 701.5K
- TLSI 39.3K
- Earning Date
- VERI 03-11-2025
- TLSI 03-27-2025
- Dividend Yield
- VERI N/A
- TLSI N/A
- EPS Growth
- VERI N/A
- TLSI N/A
- EPS
- VERI N/A
- TLSI N/A
- Revenue
- VERI $124,881,000.00
- TLSI $26,891,000.00
- Revenue This Year
- VERI N/A
- TLSI $61.29
- Revenue Next Year
- VERI N/A
- TLSI $53.21
- P/E Ratio
- VERI N/A
- TLSI N/A
- Revenue Growth
- VERI 6.94
- TLSI 67.90
- 52 Week Low
- VERI $1.66
- TLSI $3.50
- 52 Week High
- VERI $7.76
- TLSI $10.42
- Technical
- Relative Strength Index (RSI)
- VERI 42.57
- TLSI 68.94
- Support Level
- VERI $3.18
- TLSI $5.40
- Resistance Level
- VERI $3.79
- TLSI $5.82
- Average True Range (ATR)
- VERI 0.31
- TLSI 0.24
- MACD
- VERI -0.06
- TLSI 0.01
- Stochastic Oscillator
- VERI 3.57
- TLSI 89.19
About VERI Veritone Inc.
Veritone Inc is a provider of artificial intelligence (AI) computing solutions and services. It generates revenue through the delivery of its Software Products and Services which consists of revenues generated from Commercial Enterprise and Government and Regulated Industries customers using the company's aiWARE platform and hiring solutions, any related support and maintenance services, and any related professional services associated with the deployment and/or implementation of such solutions, Managed Services which consist of revenues generated from Commercial Enterprise customers using company's content licensing services, advertising agency, influencer management and related services. It has a presence in the United States, the United Kingdom, France, Australia, Israel and India.
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.